Gerson M. Struik
Papers
1
Total Citations
6
H-Index
1
About
Gerson M. Struik is a clinical researcher whose work centers on improving radiotherapy outcomes for breast cancer patients, with a particular focus on reducing treatment-related toxicity. His key research areas include accelerated partial breast irradiation (APBI), skin-sparing techniques, and the innovative use of injectable spacers to protect healthy tissue during radiation therapy. Struik’s major contribution is the development and clinical testing of hyaluronic acid spacer injections, designed to increase the distance between the skin and the target volume, thereby minimizing skin dose and toxicity in APBI. His most-cited paper, a randomized controlled trial protocol published in 2018 (6 citations), outlines a rigorous methodology to evaluate this approach, demonstrating his commitment to evidence-based practice. While his citation count is modest, his work addresses a critical clinical challenge—skin toxicity—and has the potential to significantly enhance patient quality of life. Struik’s research represents a thoughtful, patient-centered advancement in breast cancer radiotherapy, offering a practical solution to a common side effect and paving the way for safer, more tolerable treatment protocols.
Research Focus
Key Achievements
Top Papers
- 1